- Home
- TRNS vs CVAC Comparison
TRNS vs CVAC Comparison
Compare TRNS & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRNS
- CVAC
- Stock Information
- Founded
- TRNS 1964
- CVAC 2000
- Country
- TRNS United States
- CVAC Germany
- Employees
- TRNS N/A
- CVAC N/A
- Industry
- TRNS Electrical Products
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- TRNS Industrials
- CVAC Health Care
- Exchange
- TRNS Nasdaq
- CVAC Nasdaq
- Market Cap
- TRNS 982.9M
- CVAC 812.1M
- IPO Year
- TRNS N/A
- CVAC 2020
- Fundamental
- Price
- TRNS $100.34
- CVAC $4.10
- Analyst Decision
- TRNS Strong Buy
- CVAC Hold
- Analyst Count
- TRNS 4
- CVAC 3
- Target Price
- TRNS $122.75
- CVAC $10.00
- AVG Volume (30 Days)
- TRNS 73.3K
- CVAC 1.2M
- Earning Date
- TRNS 01-27-2025
- CVAC 11-12-2024
- Dividend Yield
- TRNS N/A
- CVAC N/A
- EPS Growth
- TRNS 77.19
- CVAC N/A
- EPS
- TRNS 1.98
- CVAC N/A
- Revenue
- TRNS $270,612,000.00
- CVAC $70,565,734.00
- Revenue This Year
- TRNS $10.53
- CVAC $742.57
- Revenue Next Year
- TRNS $7.78
- CVAC N/A
- P/E Ratio
- TRNS $50.70
- CVAC N/A
- Revenue Growth
- TRNS 11.42
- CVAC 75.11
- 52 Week Low
- TRNS $94.29
- CVAC $2.22
- 52 Week High
- TRNS $147.12
- CVAC $5.28
- Technical
- Relative Strength Index (RSI)
- TRNS 39.04
- CVAC 62.06
- Support Level
- TRNS $99.38
- CVAC $3.89
- Resistance Level
- TRNS $106.74
- CVAC $4.32
- Average True Range (ATR)
- TRNS 3.75
- CVAC 0.33
- MACD
- TRNS -0.44
- CVAC 0.03
- Stochastic Oscillator
- TRNS 8.98
- CVAC 54.27
About TRNS Transcat Inc.
Transcat Inc is involved in providing calibration and laboratory instrument services and distribution of test, measurement, and control instrumentation. Its product and services portfolio consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, etc. The firm has Service and Distribution operating segments. It derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Estech, FLIR, Fluke, Keysight, and Megger among others. It serves to pharmaceutical, industrial manufacturing, energy, and chemical process industries.
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.